ORAL GLUTAMINE IN THE PREVENTION OF NEONATAL NECROTIZING ENTEROCOLITIS AND OTHER GASTROINTESTINAL MUCOSAL DAMAGE - Patent 1244439

(19)

(11)

EP 1 244 439 A1

(12)

(43)	Date of publication:
	02.10.2002 Bulletin 2002/40

(21)	Application number: 99955126.0

(22)	Date of filing: 22.10.1999

(51)	International Patent Classification (IPC)⁷: A61K 31/195

(86)	International application number:
	PCT/US9924/737

(87)	International publication number:
	WO 0103/0340 (03.05.2001 Gazette 2001/18)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(71)	Applicant: Probiotix, Inc.
	Adelphi, MD 20783-1451 (US)

(72)	Inventors:
	PANIGRAHI, Pinaki Columbia,MD 21044 (US) HORVATH, Karoly Baltimore, MD 21209 (US) GEWOLB, Ira, H. Pikesville, MD 21208 (US)

(74)	Representative: Andrews, Timothy Stephen et al
	Marks & Clerk,57-60 Lincoln's Inn Fields London WC2A 3LS London WC2A 3LS (GB)

(54)	ORAL GLUTAMINE IN THE PREVENTION OF NEONATAL NECROTIZING ENTEROCOLITIS AND OTHER GASTROINTESTINAL MUCOSAL DAMAGE